Novel Approaches in Preventing and Limiting Events III Trial (NAPLES III): Bivalirudin in High-risk Bleeding Patients (NAPLESIII)

This study has been completed.
Information provided by (Responsible Party):
Carlo Briguori, Clinica Mediterranea Identifier:
First received: November 1, 2011
Last updated: April 6, 2014
Last verified: April 2014
No Study Results Posted on for this Study
  Study Status: This study has been completed.
  Study Completion Date: December 2013
  Primary Completion Date: December 2012 (Final data collection date for primary outcome measure)
No publications provided by Clinica Mediterranea

Publications automatically indexed to this study by Identifier (NCT Number):